9 Meters Biopharma, Inc. (NMTRQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Dec 25, 2024, 7:00 PM EST
9 Meters Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2016 |
| Cash & Equivalents | 6.94 | 12.65 | 46.99 | 37.85 | 4.59 | 5.73 | Upgrade
|
| Cash & Short-Term Investments | 6.94 | 12.65 | 46.99 | 37.85 | 4.59 | 5.73 | Upgrade
|
| Cash Growth | -81.37% | -73.09% | 24.15% | 724.12% | -19.83% | 1511.22% | Upgrade
|
| Prepaid Expenses | 1.57 | 3.36 | 2.99 | 1 | 0.56 | 0.5 | Upgrade
|
| Restricted Cash | 0.68 | 17.01 | - | - | - | - | Upgrade
|
| Other Current Assets | - | - | - | 0.08 | 0.08 | 0.18 | Upgrade
|
| Total Current Assets | 9.2 | 33.02 | 49.99 | 38.93 | 5.22 | 6.41 | Upgrade
|
| Property, Plant & Equipment | 0.11 | 0.12 | 0.18 | 0.23 | 0.07 | 0.04 | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 9.31 | 33.15 | 50.17 | 39.16 | 5.3 | 6.45 | Upgrade
|
| Accounts Payable | 4.23 | 5.05 | 2.43 | 1.49 | 3.89 | 3.62 | Upgrade
|
| Accrued Expenses | 5.76 | 4.38 | 5.97 | 5.29 | 4.75 | 0.93 | Upgrade
|
| Short-Term Debt | 5.07 | - | - | 0.01 | 3.18 | 5.2 | Upgrade
|
| Current Portion of Long-Term Debt | - | 19.62 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.06 | 0.06 | 0.05 | 0.05 | 0.04 | - | Upgrade
|
| Other Current Liabilities | 0.45 | 1.59 | - | 0.01 | 3.05 | 0.37 | Upgrade
|
| Total Current Liabilities | 15.58 | 30.7 | 8.46 | 6.85 | 14.91 | 10.11 | Upgrade
|
| Long-Term Leases | 0.03 | 0.05 | 0.11 | 0.17 | - | - | Upgrade
|
| Total Liabilities | 15.61 | 30.75 | 8.57 | 7.02 | 14.91 | 10.11 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.02 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 220.17 | 215.01 | 210.44 | 164.18 | 60.95 | 39.85 | Upgrade
|
| Retained Earnings | -226.48 | -212.61 | -168.84 | -132.06 | -70.56 | -43.52 | Upgrade
|
| Shareholders' Equity | -6.3 | 2.4 | 41.6 | 32.14 | -9.61 | -3.66 | Upgrade
|
| Total Liabilities & Equity | 9.31 | 33.15 | 50.17 | 39.16 | 5.3 | 6.45 | Upgrade
|
| Total Debt | 5.17 | 19.73 | 0.17 | 0.23 | 3.23 | 5.2 | Upgrade
|
| Net Cash (Debt) | 1.77 | -7.08 | 46.83 | 37.62 | 1.37 | 0.53 | Upgrade
|
| Net Cash Growth | -95.23% | - | 24.47% | 2655.19% | 156.55% | - | Upgrade
|
| Net Cash Per Share | 0.13 | -0.55 | 3.85 | 7.12 | 0.82 | 0.43 | Upgrade
|
| Filing Date Shares Outstanding | 14.46 | 14.34 | 12.91 | 10.8 | 2.07 | 1.34 | Upgrade
|
| Total Common Shares Outstanding | 14.34 | 13.04 | 12.91 | 10.23 | 1.97 | 1.3 | Upgrade
|
| Working Capital | -6.38 | 2.32 | 41.53 | 32.08 | -9.69 | -3.7 | Upgrade
|
| Book Value Per Share | -0.44 | 0.18 | 3.22 | 3.14 | -4.87 | -2.81 | Upgrade
|
| Tangible Book Value | -6.3 | 2.4 | 41.6 | 32.14 | -9.61 | -3.66 | Upgrade
|
| Tangible Book Value Per Share | -0.44 | 0.18 | 3.22 | 3.14 | -4.87 | -2.81 | Upgrade
|
| Machinery | - | 0.06 | 0.06 | 0.04 | 0.05 | 0.03 | Upgrade
|
| Leasehold Improvements | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.